NCT05859295View on ClinicalTrials.gov

Evaluation of Low-Level Light Therapy on Meibomian Glands Study

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

November 11, 2023

Study Completion Date

November 11, 2023

Conditions
Meibomian Gland DysfunctionDry Eye
Interventions
DEVICE

Red Low-Level Light Therapy

Visible red light (633nm) projected onto the face using an light emitting diode (LED) mask

Trial Locations (1)

77204

The University of Houston College of Optometry, Houston

All Listed Sponsors
collaborator

University of Louisville

OTHER

lead

University of Houston

OTHER

NCT05859295 - Evaluation of Low-Level Light Therapy on Meibomian Glands Study | Biotech Hunter | Biotech Hunter